<?xml version="1.0" encoding="UTF-8"?>
<ref id="B152-plants-10-00846">
 <label>152.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Benke</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Barberis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kopp</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Altmann</surname>
    <given-names>K.-H.</given-names>
   </name>
   <name>
    <surname>Schubiger</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vogt</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Rudolph</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>MÃ¶hler</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts</article-title>
  <source>Neuropharmacology</source>
  <year>2009</year>
  <volume>56</volume>
  <fpage>174</fpage>
  <lpage>181</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.06.013</pub-id>
 </element-citation>
</ref>
